A Quantum Leap in Medicine
Roivant Discovery is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.
Accurate All-Atom Physics-Based Simulations
We are revolutionizing the design and evolution of new medicines with our QUAISAR platform, a proprietary computational physics-driven drug design platform. Our pioneering drug discovery and development process combines quantum physics, statistical thermodynamics, molecular simulations, a dedicated supercomputing cluster, purpose-built software, in-house laboratories and clinical development capabilities.
Tweets from Roivant Discovery
Computation is having an impact on every stage of drug discovery. On this Wed/Thur at #compchemGRC, I will share some exciting developments in the #QUAISAR platform for computation-driven drug discovery and its applications, at poster 57.
We’re unraveling the relationship between binding and biological activity in induced proximity systems. Read about our pioneering research with advanced atomistic simulations, biophysics, and machine learning. http://discovery.roivant.com/dynamite
#research #drugdiscovery #QUAISAR
The #FDA has approved our first-in-class topical treatment for adults living with #PlaquePsoriasis. #SkinDeservesMore
Our website has updated information if you are curious.
A Quantum Leap in Medicine - Roivant Discovery
Roivant Discovery is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design.
We have been rapidly expanding our drug discovery capabilities beyond traditional small molecules to now encompass #heterobifunctionals and #covalency, where we use state-of-the-art #massspectrometry (MS) and #machinelearning (ML) to access the “dark” protein sequence space.
The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery
The emerging role of mass spectrometry-based proteomics in drug discovery
Nature Reviews Drug Discovery - System-wide methods to monitor protein activity are still underused in drug discovery....